Report Detail
Global NK Cells Market Insights and Forecast to 2026
- RnM4115234 |
- 05 August, 2020 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
NK Cells market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global NK Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the NK Cells market is segmented into
Mogamulizumab
Lorvotuzumab Mertansine
Others
Segment by Application, the NK Cells market is segmented into
Cancer
Cardiovascular Diseases
Others
Regional and Country-level Analysis
The NK Cells market is analysed and market size information is provided by regions (countries).
The key regions covered in the NK Cells market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and NK Cells Market Share Analysis
NK Cells market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in NK Cells business, the date to enter into the NK Cells market, NK Cells product introduction, recent developments, etc.
The major vendors covered:
Chipscreen Biosciences (China)
Affimed NV (Netherlands)
Altor BioScience Corporation (USA)
Innate Pharma SA (France)
Takeda Pharmaceutical (Japan)
Sorrento Therapeutics Inc. (USA)
NantKwest Inc. (USA)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)
1 Study Coverage
- 1.1 NK Cells Product Introduction
- 1.2 Market Segments
- 1.3 Key NK Cells Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global NK Cells Market Size Growth Rate by Type
- 1.4.2 Mogamulizumab
- 1.4.3 Lorvotuzumab Mertansine
- 1.4.4 Others
- 1.5 Market by Application
- 1.5.1 Global NK Cells Market Size Growth Rate by Application
- 1.5.2 Cancer
- 1.5.3 Cardiovascular Diseases
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global NK Cells Market Size, Estimates and Forecasts
- 2.1.1 Global NK Cells Revenue 2015-2026
- 2.1.2 Global NK Cells Sales 2015-2026
- 2.2 Global NK Cells, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global NK Cells Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global NK Cells Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global NK Cells Competitor Landscape by Players
- 3.1 NK Cells Sales by Manufacturers
- 3.1.1 NK Cells Sales by Manufacturers (2015-2020)
- 3.1.2 NK Cells Sales Market Share by Manufacturers (2015-2020)
- 3.2 NK Cells Revenue by Manufacturers
- 3.2.1 NK Cells Revenue by Manufacturers (2015-2020)
- 3.2.2 NK Cells Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global NK Cells Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by NK Cells Revenue in 2019
- 3.2.5 Global NK Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 NK Cells Price by Manufacturers
- 3.4 NK Cells Manufacturing Base Distribution, Product Types
- 3.4.1 NK Cells Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers NK Cells Product Type
- 3.4.3 Date of International Manufacturers Enter into NK Cells Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global NK Cells Market Size by Type (2015-2020)
- 4.1.1 Global NK Cells Sales by Type (2015-2020)
- 4.1.2 Global NK Cells Revenue by Type (2015-2020)
- 4.1.3 NK Cells Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global NK Cells Market Size Forecast by Type (2021-2026)
- 4.2.1 Global NK Cells Sales Forecast by Type (2021-2026)
- 4.2.2 Global NK Cells Revenue Forecast by Type (2021-2026)
- 4.2.3 NK Cells Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global NK Cells Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global NK Cells Market Size by Application (2015-2020)
- 5.1.1 Global NK Cells Sales by Application (2015-2020)
- 5.1.2 Global NK Cells Revenue by Application (2015-2020)
- 5.1.3 NK Cells Price by Application (2015-2020)
- 5.2 NK Cells Market Size Forecast by Application (2021-2026)
- 5.2.1 Global NK Cells Sales Forecast by Application (2021-2026)
- 5.2.2 Global NK Cells Revenue Forecast by Application (2021-2026)
- 5.2.3 Global NK Cells Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America NK Cells by Country
- 6.1.1 North America NK Cells Sales by Country
- 6.1.2 North America NK Cells Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America NK Cells Market Facts & Figures by Type
- 6.3 North America NK Cells Market Facts & Figures by Application
7 Europe
- 7.1 Europe NK Cells by Country
- 7.1.1 Europe NK Cells Sales by Country
- 7.1.2 Europe NK Cells Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe NK Cells Market Facts & Figures by Type
- 7.3 Europe NK Cells Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific NK Cells by Region
- 8.1.1 Asia Pacific NK Cells Sales by Region
- 8.1.2 Asia Pacific NK Cells Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific NK Cells Market Facts & Figures by Type
- 8.3 Asia Pacific NK Cells Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America NK Cells by Country
- 9.1.1 Latin America NK Cells Sales by Country
- 9.1.2 Latin America NK Cells Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America NK Cells Market Facts & Figures by Type
- 9.3 Central & South America NK Cells Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa NK Cells by Country
- 10.1.1 Middle East and Africa NK Cells Sales by Country
- 10.1.2 Middle East and Africa NK Cells Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa NK Cells Market Facts & Figures by Type
- 10.3 Middle East and Africa NK Cells Market Facts & Figures by Application
11 Company Profiles
- 11.1 Chipscreen Biosciences (China)
- 11.1.1 Chipscreen Biosciences (China) Corporation Information
- 11.1.2 Chipscreen Biosciences (China) Description and Business Overview
- 11.1.3 Chipscreen Biosciences (China) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Chipscreen Biosciences (China) NK Cells Products Offered
- 11.1.5 Chipscreen Biosciences (China) Related Developments
- 11.2 Affimed NV (Netherlands)
- 11.2.1 Affimed NV (Netherlands) Corporation Information
- 11.2.2 Affimed NV (Netherlands) Description and Business Overview
- 11.2.3 Affimed NV (Netherlands) Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Affimed NV (Netherlands) NK Cells Products Offered
- 11.2.5 Affimed NV (Netherlands) Related Developments
- 11.3 Altor BioScience Corporation (USA)
- 11.3.1 Altor BioScience Corporation (USA) Corporation Information
- 11.3.2 Altor BioScience Corporation (USA) Description and Business Overview
- 11.3.3 Altor BioScience Corporation (USA) Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Altor BioScience Corporation (USA) NK Cells Products Offered
- 11.3.5 Altor BioScience Corporation (USA) Related Developments
- 11.4 Innate Pharma SA (France)
- 11.4.1 Innate Pharma SA (France) Corporation Information
- 11.4.2 Innate Pharma SA (France) Description and Business Overview
- 11.4.3 Innate Pharma SA (France) Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Innate Pharma SA (France) NK Cells Products Offered
- 11.4.5 Innate Pharma SA (France) Related Developments
- 11.5 Takeda Pharmaceutical (Japan)
- 11.5.1 Takeda Pharmaceutical (Japan) Corporation Information
- 11.5.2 Takeda Pharmaceutical (Japan) Description and Business Overview
- 11.5.3 Takeda Pharmaceutical (Japan) Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Takeda Pharmaceutical (Japan) NK Cells Products Offered
- 11.5.5 Takeda Pharmaceutical (Japan) Related Developments
- 11.6 Sorrento Therapeutics Inc. (USA)
- 11.6.1 Sorrento Therapeutics Inc. (USA) Corporation Information
- 11.6.2 Sorrento Therapeutics Inc. (USA) Description and Business Overview
- 11.6.3 Sorrento Therapeutics Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Sorrento Therapeutics Inc. (USA) NK Cells Products Offered
- 11.6.5 Sorrento Therapeutics Inc. (USA) Related Developments
- 11.7 NantKwest Inc. (USA)
- 11.7.1 NantKwest Inc. (USA) Corporation Information
- 11.7.2 NantKwest Inc. (USA) Description and Business Overview
- 11.7.3 NantKwest Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 NantKwest Inc. (USA) NK Cells Products Offered
- 11.7.5 NantKwest Inc. (USA) Related Developments
- 11.8 Bristol-Myers Squibb (USA)
- 11.8.1 Bristol-Myers Squibb (USA) Corporation Information
- 11.8.2 Bristol-Myers Squibb (USA) Description and Business Overview
- 11.8.3 Bristol-Myers Squibb (USA) Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Bristol-Myers Squibb (USA) NK Cells Products Offered
- 11.8.5 Bristol-Myers Squibb (USA) Related Developments
- 11.9 NKT Therapeutics (USA)
- 11.9.1 NKT Therapeutics (USA) Corporation Information
- 11.9.2 NKT Therapeutics (USA) Description and Business Overview
- 11.9.3 NKT Therapeutics (USA) Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 NKT Therapeutics (USA) NK Cells Products Offered
- 11.9.5 NKT Therapeutics (USA) Related Developments
- 11.1 Chipscreen Biosciences (China)
- 11.1.1 Chipscreen Biosciences (China) Corporation Information
- 11.1.2 Chipscreen Biosciences (China) Description and Business Overview
- 11.1.3 Chipscreen Biosciences (China) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Chipscreen Biosciences (China) NK Cells Products Offered
- 11.1.5 Chipscreen Biosciences (China) Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 NK Cells Market Estimates and Projections by Region
- 12.1.1 Global NK Cells Sales Forecast by Regions 2021-2026
- 12.1.2 Global NK Cells Revenue Forecast by Regions 2021-2026
- 12.2 North America NK Cells Market Size Forecast (2021-2026)
- 12.2.1 North America: NK Cells Sales Forecast (2021-2026)
- 12.2.2 North America: NK Cells Revenue Forecast (2021-2026)
- 12.2.3 North America: NK Cells Market Size Forecast by Country (2021-2026)
- 12.3 Europe NK Cells Market Size Forecast (2021-2026)
- 12.3.1 Europe: NK Cells Sales Forecast (2021-2026)
- 12.3.2 Europe: NK Cells Revenue Forecast (2021-2026)
- 12.3.3 Europe: NK Cells Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific NK Cells Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: NK Cells Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: NK Cells Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: NK Cells Market Size Forecast by Region (2021-2026)
- 12.5 Latin America NK Cells Market Size Forecast (2021-2026)
- 12.5.1 Latin America: NK Cells Sales Forecast (2021-2026)
- 12.5.2 Latin America: NK Cells Revenue Forecast (2021-2026)
- 12.5.3 Latin America: NK Cells Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa NK Cells Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: NK Cells Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: NK Cells Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: NK Cells Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key NK Cells Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 NK Cells Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on NK Cells. Industry analysis & Market Report on NK Cells is a syndicated market report, published as Global NK Cells Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of NK Cells market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
